{"ticker": {"uuid": "e048f538-7feb-41e7-93f9-74bd85ac2c2b", "symbol": "BCT", "name": "BriaCell Therapeutics Corp.", "exchange": "TOR", "country": "CA", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Briacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE90aDVGUnJQbldhaEJBdkxPaU1tZzBybVVESlg1T2VFOWxhTEl6UDZMcUlTUk1kcVctdWZyX3l6NGJUenBLenczQXlIeWprY3E5S1B1c2tZWURvaHhGblh5MWlKUkU2MFNDdmU0b2VGZDZ6ajVjZnNv?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T02:28:58+00:00", "published_display": "18 Jun 2026 02:28", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Briacell Therapeutics Corp stock is tanking today", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQTmtDcTZvcVByZ0pjYnMwNTRqeWw3YUttckk5Q1FrZTE2VWstQzQ1ZTBWQmFnRmZ5dDZlUDdEZzhMSV9LazdoczROYU5xWHJGckNoc3Q0YmhINWVEUjJaMnVydkl5QW1QNWUzRVJUSXZHMUFfeUhaa29URXBzU3NVNm5uSFJ0VElYekcyMzVVRjFiQQ?oc=5", "source_name": "Wealth Awesome", "published_at": "2026-06-18T02:01:01+00:00", "published_display": "18 Jun 2026 02:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Briacell Therapeutics Corp stock is rising today", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNaVNCVVI2M0VHODlIYnI1UWJMTUJGYXlWNXNITElBZ0JDR1J2VHRUMHY5bGhPd3EycW9lN2ZpcS03LTRQUFc2Nnk1b1hKMl85a24tclM1U2djdFo1OFpPTGFlNzVmckd3bDUwZlJkWmlmRjdnSDdUXzlYSmIzOC1sMlZqcEhPTGFaTHBiaWN3M0Q?oc=5", "source_name": "Wealth Awesome", "published_at": "2026-06-12T14:55:05+00:00", "published_display": "12 Jun 2026 14:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Therapeutics Completes Equity Offering to Fund Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxOdlUwOExtTmlPdTVEVTJoSW5pRERyQTVhVnRabHkxTGh0bTlkT3MxbkE3RHZrRnRvaHZQTWt2bjBGM1IzUVZ5bTB0dnYydmt5aTMyaFNnUGhlel9xVV82UFhxNDAyTnJDNmZZRC1YVFFSMW93TXhVeFZKd0FqbmZ2YjRaQzZSdFRiUWtfZGc2M28tRFVVYTFZNl9GcmFXTXJCZ1BnYkpRRlRtNnY0OTNnZU8tR2wyY1Fpd3l6NE11N3dDdHVMUkVqMEN5OXpYYkpHWmYxM054d29zWlFZUTBabThoT0JpZw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell (NASDAQ: BCTX) completes $4.71M best efforts common share sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNY3psc1hnX0dabjVlNHR2QUhuVE5qeEFEOFBZWjVrZWZGR2xGU2RLaG4yeHBQbkVwZkRsWExhU2NiSXVFQnhqUEl0V3lLX0cyN2RUMkhyWGNNUGg3ZVM3MUZZbElMbEtCN2Zzb3hmRDBBbjZnX2F2WHMwZTZjM2c4UW5pZVJBcmtQNFdWWFV4MVNYaXp3RGhDazFoc2Fkb3JraUhUdGk4VTM4MDkteDlPZmR1RU1fLTA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Presenting Final Phase 2, Ongoing Phase 3 Data at ASCO Meeting", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNX1c5eGVJcWxMeWg5T3Ixd2p4Y3VrYlBoRUVMOHZNZEhRMUxsUHlpV1M5N1hrclpOOXgtSXlEMEhITzJtSHpxNVBYck91OFFTRWlmTVhKaUM3WHJjRUdXT1lLSm92dU41QXFXN0VsOEZtdTBMNjRNcWQ3RE5RVXlQdG1MeVhxVkJYd2Y1X3M1cW1FTDRVUG9RSjJmOWVaOERwQ3ZSc0ZwcGxsRThXc1A5eGtsX2puX2x1Z0RjQkZfdHk?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxORXhoWEl4MGN6eGRneG9PZUdwamVVTDhza3JOaG00OElGdTlTMHI2cnlwWDlMTnlEN2V2WHcyeHNCczVZSklEd25mMUNqT1p1c0VwbV9wcGZOejhxNll5d3htcGR0S2xGbUpGUE84THI4Si1jamp2YlJpNlBObWRWeENEZHVTM19lNjlpbFp6cjN3M196R0lLZTFTSDhweU5vZ0hFTFVDYWVPR2ZrYUg5MkQ0NV9DUTZtSFphQ1RlZ0JDd25reFVsWnVoSWlnLTlYQTdoQV9Pcy1Bek0?oc=5", "source_name": "TradingView", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Phase 3 Bria-IMT\u2122 Study Enrollment Surpasses 230 Patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOUmtlaGFQR2F1dGNOclpnaWVlRG5henB2VFpwX0NZSUVJd2MzRUFhTTlSLUluZ2FSYkU3TnNGUFRYYzJDT1l5eXlCc3dDR2dkZF9Mbk8yWkItMWZGOVNiMHNDOGFLYTZnWV9tTWRsSGxJNDVEam82b25HdzM2TzZtMks5WjhyV0ZaY1VSWXk4bDhuNGJBejZNd2J3VThMQjNRY0JyLW1RMjUxandQOG5FcHJ5TGtTOG9qek5VaVNldzZvWm5IMjR3YW9YOFNiRlRZNEE0?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Therapeutics stock plummets after $30 million offering By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQNzRpRGsyZzJOQlIxNTJWdnhtdEEzbzU2VHd3bVA4d1RuV1gybEx6bS1DUXJHdmRSRUNLNHRReF8zSWt5LVhMcmx3Q2tTMWN4MThfM2hYVndaUnlJcUdEaXZjRTdDTklzaUs4NXNWVmFOVVIzSl8yUG5Ia1E5dnBORTVfeXpFV3B4VVZZTzh2MDRjVW5nMU5Qd2duYmpYM2xyUUZLZmt3WHJySjZGVzlWeU95azdMX0lSUXRaYlVnNlU?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Therapeutics stock plummets after $30 million offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQaFhVU2JKU1NzaGVlV2lQUHFwYjFiWTYxMWVYSWc2UVBUcWtEVndiTXF5cUl6dlVQdV9zVzNpUUthT2o4bWVOamZodThNckRMTFhDaTF0SzZxbXlfd2RzUjR6SWhCZHNEMTBHSU9FQU92UG5pMmpzbThlbmpRM2RGem1WMkpoVjY2ekV5TTc4blM5WXpEU1AzNXdJTVJ5bGc0T0NHMXdldTF2cWxSRFp0cTVmRzQxODJRb0o0R2VvMzVaQQ?oc=5", "source_name": "Investing.com", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're A Bit Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE1VdzY4dVo2Vkh1WS0yY2xRdmQ3WW91aExvZVh6b2lFdHR3X0k2aWRlNUd6TDgxTWw2SGxPNk9CbWdYbldnTTR5UzVEN1Z3djlBZHdFNnduRmpnOV9PZktqbTFnT0ZBZ1liRHJwR3ZRazFUejlBbnBXVXpYdHQ?oc=5", "source_name": "Market source", "published_at": "2025-06-25T07:00:00+00:00", "published_display": "25 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Therapeutics Corp (BCT:CT): Stock Price, Quote and News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1WWU9nZkVSQ0tXZXg5OG5SYWxLUzd0Si1MaXR5RlRLMElxRGMyLVJSRWdYVXFmUW5rYkViQjYtQWFMQkQ5QWx1cjY0bTV3SXlmcC1B?oc=5", "source_name": "BNN Bloomberg", "published_at": "2025-01-20T20:24:58+00:00", "published_display": "20 Jan 2025 20:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPdnhpUDA5T0FtTk9US2lxSU9rTENCZkpsYm1IVG5ZUXVDR2xwZDU0dUdkUU85dTQ3M1g1Rlo5Z2dVdWxGVHRnMEVYOVROMUJ5eVdtZVFGSlZMRHp2bnFXamhwdGJqWUtzaTJEMVR1WE5zRnAwWmVxS2s3SW1yVDNxSzVnRkhCb1JPbFZ3RDRPb2NSeUM2WXpvWFhvaXZ0ajVHWTJaQTcwV2gyQ3BL?oc=5", "source_name": "Seeking Alpha", "published_at": "2024-10-22T07:00:00+00:00", "published_display": "22 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Market Volatility Impact BriaCell Therapeutics Corp.'s (CVE:BCT) Share Price?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQRUZuM1JWeVFWRERoTFNTcDZELVNqNW5td0lhSVFuaFBtR2U4UzB0M241Q2dLMVZ6bWVKYnp2S21XV1VJMlBTSjN2cmhJcFY3ZEhZREc3dTNnNFBXUVoyUGltUGlsNnNrQ0xxSmJsYkdZNUtrUkYyM2pPbC1oNXdjLURGNHdLcVdENWdTMw?oc=5", "source_name": "Market source", "published_at": "2019-07-09T07:00:00+00:00", "published_display": "09 Jul 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Briacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE90aDVGUnJQbldhaEJBdkxPaU1tZzBybVVESlg1T2VFOWxhTEl6UDZMcUlTUk1kcVctdWZyX3l6NGJUenBLenczQXlIeWprY3E5S1B1c2tZWURvaHhGblh5MWlKUkU2MFNDdmU0b2VGZDZ6ajVjZnNv?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T02:28:58+00:00", "published_display": "18 Jun 2026 02:28", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Briacell Therapeutics Corp stock is tanking today", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQTmtDcTZvcVByZ0pjYnMwNTRqeWw3YUttckk5Q1FrZTE2VWstQzQ1ZTBWQmFnRmZ5dDZlUDdEZzhMSV9LazdoczROYU5xWHJGckNoc3Q0YmhINWVEUjJaMnVydkl5QW1QNWUzRVJUSXZHMUFfeUhaa29URXBzU3NVNm5uSFJ0VElYekcyMzVVRjFiQQ?oc=5", "source_name": "Wealth Awesome", "published_at": "2026-06-18T02:01:01+00:00", "published_display": "18 Jun 2026 02:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Briacell Therapeutics Corp stock is rising today", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNaVNCVVI2M0VHODlIYnI1UWJMTUJGYXlWNXNITElBZ0JDR1J2VHRUMHY5bGhPd3EycW9lN2ZpcS03LTRQUFc2Nnk1b1hKMl85a24tclM1U2djdFo1OFpPTGFlNzVmckd3bDUwZlJkWmlmRjdnSDdUXzlYSmIzOC1sMlZqcEhPTGFaTHBiaWN3M0Q?oc=5", "source_name": "Wealth Awesome", "published_at": "2026-06-12T14:55:05+00:00", "published_display": "12 Jun 2026 14:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Therapeutics Completes Equity Offering to Fund Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxOdlUwOExtTmlPdTVEVTJoSW5pRERyQTVhVnRabHkxTGh0bTlkT3MxbkE3RHZrRnRvaHZQTWt2bjBGM1IzUVZ5bTB0dnYydmt5aTMyaFNnUGhlel9xVV82UFhxNDAyTnJDNmZZRC1YVFFSMW93TXhVeFZKd0FqbmZ2YjRaQzZSdFRiUWtfZGc2M28tRFVVYTFZNl9GcmFXTXJCZ1BnYkpRRlRtNnY0OTNnZU8tR2wyY1Fpd3l6NE11N3dDdHVMUkVqMEN5OXpYYkpHWmYxM054d29zWlFZUTBabThoT0JpZw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell (NASDAQ: BCTX) completes $4.71M best efforts common share sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNY3psc1hnX0dabjVlNHR2QUhuVE5qeEFEOFBZWjVrZWZGR2xGU2RLaG4yeHBQbkVwZkRsWExhU2NiSXVFQnhqUEl0V3lLX0cyN2RUMkhyWGNNUGg3ZVM3MUZZbElMbEtCN2Zzb3hmRDBBbjZnX2F2WHMwZTZjM2c4UW5pZVJBcmtQNFdWWFV4MVNYaXp3RGhDazFoc2Fkb3JraUhUdGk4VTM4MDkteDlPZmR1RU1fLTA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Presenting Final Phase 2, Ongoing Phase 3 Data at ASCO Meeting", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNX1c5eGVJcWxMeWg5T3Ixd2p4Y3VrYlBoRUVMOHZNZEhRMUxsUHlpV1M5N1hrclpOOXgtSXlEMEhITzJtSHpxNVBYck91OFFTRWlmTVhKaUM3WHJjRUdXT1lLSm92dU41QXFXN0VsOEZtdTBMNjRNcWQ3RE5RVXlQdG1MeVhxVkJYd2Y1X3M1cW1FTDRVUG9RSjJmOWVaOERwQ3ZSc0ZwcGxsRThXc1A5eGtsX2puX2x1Z0RjQkZfdHk?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxORXhoWEl4MGN6eGRneG9PZUdwamVVTDhza3JOaG00OElGdTlTMHI2cnlwWDlMTnlEN2V2WHcyeHNCczVZSklEd25mMUNqT1p1c0VwbV9wcGZOejhxNll5d3htcGR0S2xGbUpGUE84THI4Si1jamp2YlJpNlBObWRWeENEZHVTM19lNjlpbFp6cjN3M196R0lLZTFTSDhweU5vZ0hFTFVDYWVPR2ZrYUg5MkQ0NV9DUTZtSFphQ1RlZ0JDd25reFVsWnVoSWlnLTlYQTdoQV9Pcy1Bek0?oc=5", "source_name": "TradingView", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Phase 3 Bria-IMT\u2122 Study Enrollment Surpasses 230 Patients", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOUmtlaGFQR2F1dGNOclpnaWVlRG5henB2VFpwX0NZSUVJd2MzRUFhTTlSLUluZ2FSYkU3TnNGUFRYYzJDT1l5eXlCc3dDR2dkZF9Mbk8yWkItMWZGOVNiMHNDOGFLYTZnWV9tTWRsSGxJNDVEam82b25HdzM2TzZtMks5WjhyV0ZaY1VSWXk4bDhuNGJBejZNd2J3VThMQjNRY0JyLW1RMjUxandQOG5FcHJ5TGtTOG9qek5VaVNldzZvWm5IMjR3YW9YOFNiRlRZNEE0?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Therapeutics stock plummets after $30 million offering By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQNzRpRGsyZzJOQlIxNTJWdnhtdEEzbzU2VHd3bVA4d1RuV1gybEx6bS1DUXJHdmRSRUNLNHRReF8zSWt5LVhMcmx3Q2tTMWN4MThfM2hYVndaUnlJcUdEaXZjRTdDTklzaUs4NXNWVmFOVVIzSl8yUG5Ia1E5dnBORTVfeXpFV3B4VVZZTzh2MDRjVW5nMU5Qd2duYmpYM2xyUUZLZmt3WHJySjZGVzlWeU95azdMX0lSUXRaYlVnNlU?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Therapeutics stock plummets after $30 million offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQaFhVU2JKU1NzaGVlV2lQUHFwYjFiWTYxMWVYSWc2UVBUcWtEVndiTXF5cUl6dlVQdV9zVzNpUUthT2o4bWVOamZodThNckRMTFhDaTF0SzZxbXlfd2RzUjR6SWhCZHNEMTBHSU9FQU92UG5pMmpzbThlbmpRM2RGem1WMkpoVjY2ekV5TTc4blM5WXpEU1AzNXdJTVJ5bGc0T0NHMXdldTF2cWxSRFp0cTVmRzQxODJRb0o0R2VvMzVaQQ?oc=5", "source_name": "Investing.com", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're A Bit Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE1VdzY4dVo2Vkh1WS0yY2xRdmQ3WW91aExvZVh6b2lFdHR3X0k2aWRlNUd6TDgxTWw2SGxPNk9CbWdYbldnTTR5UzVEN1Z3djlBZHdFNnduRmpnOV9PZktqbTFnT0ZBZ1liRHJwR3ZRazFUejlBbnBXVXpYdHQ?oc=5", "source_name": "Market source", "published_at": "2025-06-25T07:00:00+00:00", "published_display": "25 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Therapeutics Corp (BCT:CT): Stock Price, Quote and News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1WWU9nZkVSQ0tXZXg5OG5SYWxLUzd0Si1MaXR5RlRLMElxRGMyLVJSRWdYVXFmUW5rYkViQjYtQWFMQkQ5QWx1cjY0bTV3SXlmcC1B?oc=5", "source_name": "BNN Bloomberg", "published_at": "2025-01-20T20:24:58+00:00", "published_display": "20 Jan 2025 20:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPdnhpUDA5T0FtTk9US2lxSU9rTENCZkpsYm1IVG5ZUXVDR2xwZDU0dUdkUU85dTQ3M1g1Rlo5Z2dVdWxGVHRnMEVYOVROMUJ5eVdtZVFGSlZMRHp2bnFXamhwdGJqWUtzaTJEMVR1WE5zRnAwWmVxS2s3SW1yVDNxSzVnRkhCb1JPbFZ3RDRPb2NSeUM2WXpvWFhvaXZ0ajVHWTJaQTcwV2gyQ3BL?oc=5", "source_name": "Seeking Alpha", "published_at": "2024-10-22T07:00:00+00:00", "published_display": "22 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Market Volatility Impact BriaCell Therapeutics Corp.'s (CVE:BCT) Share Price?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQRUZuM1JWeVFWRERoTFNTcDZELVNqNW5td0lhSVFuaFBtR2U4UzB0M241Q2dLMVZ6bWVKYnp2S21XV1VJMlBTSjN2cmhJcFY3ZEhZREc3dTNnNFBXUVoyUGltUGlsNnNrQ0xxSmJsYkdZNUtrUkYyM2pPbC1oNXdjLURGNHdLcVdENWdTMw?oc=5", "source_name": "Market source", "published_at": "2019-07-09T07:00:00+00:00", "published_display": "09 Jul 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 69, "total_relevant": 14, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 13, "score": 45, "total": 14, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 93, "events": [{"event": "general", "label": "Market update", "weight": 7.85, "count": 13}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 4.11, "latest_week": "2026-06-19", "one_week_move": 8.2, "four_week_move": -14.2, "twelve_week_move": -20.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.686672, "market_dynamics_buy_signal": false, "relative_strength": -67.72389, "fair_value_gap": -98.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 39.0691, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+8.2% over one week, -14.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 69, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Wealth Awesome", "count": 2}, {"label": "Market source", "count": 2}, {"label": "TradingKey", "count": 1}, {"label": "The Globe and Mail", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "marketscreener.com", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "GlobeNewswire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "45/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "93/100 classification confidence."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+8.2% over one week, -14.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Briacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk"}], "updated_at": "2026-06-22T20:02:29.687038+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}